Hospital-Acquired Infections in the NICU: Epidemiology for the New Millennium

Clinics in Perinatology

Volumn 35, Issue 1, 2008, Pages 223-249

  Carey, Alison J ^a   Saiman, Lisa ^a   Polin, Richard A ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; VANCOMYCIN; VIRULENCE FACTOR;

BACTEREMIA; BACTERIAL ARTHRITIS; BACTERIAL COLONIZATION; CANDIDA; CATHETER INFECTION; CEREBROSPINAL FLUID ANALYSIS; CHILD HOSPITALIZATION; CLINICAL FEATURE; DRUG BLOOD LEVEL; DRUG EFFICACY; ENDOCARDITIS; EPIDEMIC; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; MENINGITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NEPHROTOXICITY; NEWBORN INTENSIVE CARE; OSTEOMYELITIS; OTOTOXICITY; PATHOPHYSIOLOGY; PREMATURITY; PRIORITY JOURNAL; REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION;

CANDIDIASIS; CROSS INFECTION; DISEASE SUSCEPTIBILITY; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTENSIVE CARE UNITS, NEONATAL; MENINGITIS; METHICILLIN RESISTANCE; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; UNITED STATES;

EID: 39049119377     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2007.11.014     Document Type: Review

References (108)

1. Dunn P.M. Ignac Semmelweis (1818-1865) of Budapest and the prevention of puerperal fever. Arch Dis Child Fetal Neonatal Ed 90 4 (2005) F345-F348
2. Wenzel R.P., and Edmond M.B. Team-based prevention of catheter-related infections. N Engl J Med 355 26 (2006) 2781-2783
3. Payne N.R., Carpenter J.H., Badger G.J., et al. Marginal increase in cost and excess length of stay associated with nosocomial bloodstream infections in surviving very low birth weight infants. Pediatrics 114 2 (2004) 348-355
4. Stoll B.J., Hansen N.I., Adams-Chapman I., et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 292 19 (2004) 2357-2365
5. Aly H., Herson V., Duncan A., et al. Is bloodstream infection preventable among premature infants? A tale of two cities. Pediatrics 115 6 (2005) 1513-1518
6. Horbar J.D., Rogowski J., Plsek P.E., et al. Collaborative quality improvement for neonatal intensive care. NIC/Q Project Investigators of the Vermont Oxford Network. Pediatrics 107 1 (2001) 14-22
7. Klinger G., Chin C.N., Beyene J., et al. Predicting the outcome of neonatal bacterial meningitis. Pediatrics 106 3 (2000) 477-482
8. Stoll B.J., Hansen N., Fanaroff A.A., et al. To tap or not to tap: high likelihood of meningitis without sepsis among very low birth weight infants. Pediatrics 113 5 (2004) 1181-1186
9. Benjamin Jr. D.K., Stoll B.J., Fanaroff A.A., et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 117 1 (2006) 84-92
10. Sarff L.D., Platt L.H., and McCracken Jr. G.H. Cerebrospinal fluid evaluation in neonates: comparison of high-risk infants with and without meningitis. J Pediatr 88 3 (1976) 473-477
11. Garges H.P., Moody M.A., Cotten C.M., et al. Neonatal meningitis: what is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters?. Pediatrics 117 4 (2006) 1094-1100
12. Krebs V.L., Okay T.S., Okay Y., et al. Tumor necrosis factor-alpha, interleukin-1beta and interleukin-6 in the cerebrospinal fluid of newborn with meningitis. Arq Neuropsiquiatr 63 1 (2005) 7-13
13. Dulkerian S.J., Kilpatrick L., Costarino Jr. A.T., et al. Cytokine elevations in infants with bacterial and aseptic meningitis. J Pediatr 126 6 (1995) 872-876
14. Boyce J.M. Increasing prevalence of methicillin-resistant Staphylococcus aureus in the United States. Infect Control Hosp Epidemiol 11 12 (1990) 639-642
15. Saiman L. Preventing infections in the neonatal intensive care unit. In: Wenzel R. (Ed). Prevention and control of nosocomial infections. 4th edition (2003), Lippincott, Williams & Wilkins, Hagerstown (MD) p. 345
16. Stoll B.J., and Hansen N. Infections in VLBW infants: studies from the NICHD Neonatal Research Network. Semin Perinatol 27 4 (2003) 293-301
17. Banerjee S.N., Grohskopf L.A., Sinkowitz-Cochran R.L., et al. Incidence of pediatric and neonatal intensive care unit-acquired infections. Infect Control Hosp Epidemiol 27 6 (2006) 561-570
18. Baltimore R.S. Neonatal nosocomial infections. Semin Perinatol 22 1 (1998) 25-32
19. Tiemersma E.W., Bronzwaer S.L., Lyytikainen O., et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 10 9 (2004) 1627-1634
20. Stoll B.J., Hansen N., Fanaroff A.A., et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 347 4 (2002) 240-247
21. Stoll B.J., Hansen N., Fanaroff A.A., et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 110 2 Pt 1 (2002) 285-291
22. Gonzalez B.E., Martinez-Aguilar G., Hulten K.G., et al. Severe staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics 115 3 (2005) 642-648
23. Miller L.G., Perdreau-Remington F., Rieg G., et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 352 14 (2005) 1445-1453
24. Mishaan A.M., Mason Jr. E.O., Martinez-Aguilar G., et al. Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas. Pediatr Infect Dis J 24 3 (2005) 201-206
25. Lowy F.D., Aiello A.E., Bhat M., et al. Staphylococcus aureus colonization and infection in New York State prisons. J Infect Dis 196 6 (2007) 911-918
26. Lee N.E., Taylor M.M., Bancroft E., et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clin Infect Dis 40 10 (2005) 1529-1534
27. Zinderman C.E., Conner B., Malakooti M.A., et al. Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerg Infect Dis 10 5 (2004) 941-944
28. James L., Gorwitz R.J., Jones R.C., et al. Methicillin-resistant Staphylococcus aureus infections among healthy full-term newborns. Arch Dis Child Fetal Neonatal Ed 93 (2008) 40-44
29. Morel A.S., Wu F., Della-Latta P., et al. Nosocomial transmission of methicillin-resistant Staphylococcus aureus from a mother to her preterm quadruplet infants. Am J Infect Control 30 3 (2002) 170-173
30. Saiman L., O'Keefe M., Graham III P.L., et al. Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin Infect Dis 37 10 (2003) 1313-1319
31. Chen K.T., Huard R.C., Della-Latta P., et al. Prevalence of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in pregnant women. Obstet Gynecol 108 3 Pt 1 (2006) 482-487
32. Behari P., Englund J., Alcasid G., et al. Transmission of methicillin-resistant Staphylococcus aureus to preterm infants through breast milk. Infect Control Hosp Epidemiol 25 9 (2004) 778-780
33. Gastelum D.T., Dassey D., Mascola L., et al. Transmission of community-associated methicillin-resistant Staphylococcus aureus from breast milk in the neonatal intensive care unit. Pediatr Infect Dis J 24 12 (2005) 1122-1124
34. von Eiff C., Becker K., Machka K., et al. Nasal carriage as a source of Staphylococcus aureus bacteremia: study group. N Engl J Med 344 1 (2001) 11-16
35. Saiman L., Ludington E., Dawson J.D., et al. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J 20 12 (2001) 1119-1124
36. Waters V., Larson E., Wu F., et al. Molecular epidemiology of gram-negative bacilli from infected neonates and health care workers' hands in neonatal intensive care units. Clin Infect Dis 38 12 (2004) 1682-1687
37. Saiman L., Cronquist A., Wu F., et al. An outbreak of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol 24 5 (2003) 317-321
38. Diederen B.M., and Kluytmans J.A. The emergence of infections with community-associated methicillin resistant Staphylococcus aureus. J Infect 52 3 (2006) 157-168
39. Graham III P.L., Lin S.X., and Larson E.L. A US population-based survey of Staphylococcus aureus colonization. Ann Intern Med 144 5 (2006) 318-325
40. Davis S.L., Rybak M.J., Amjad M., et al. Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 27 10 (2006) 1025-1031
41. Tsuji B.T., Rybak M.J., Cheung C.M., et al. Community- and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents. Diagn Microbiol Infect Dis 58 1 (2007) 41-47
42. Said-Salim B., Mathema B., Braughton K., et al. Differential distribution and expression of Panton-Valentine leucocidin among community-acquired methicillin-resistant Staphylococcus aureus strains. J Clin Microbiol 43 7 (2005) 3373-3379
43. Steinkraus G., White R., and Friedrich L. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S aureus (MRSA) blood isolates from 2001-2005. J Antimicrob Chemother 60 4 (2007) 788-794
44. Howden B.P., Ward P.B., Charles P.G.P., et al. Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis 38 (2004) 521-528
45. Cunha B.A. Methicillin-resistant Staphylococcus aureus: clinical manifestations and antimicrobial therapy. Clin Microbiol Infect 11 Suppl 4 (2005) 33-42
46. Tiwari H.K., and Sen M.R. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. BMC Infect Dis 6 (2006) 156-161
47. Hanaki H., Hososaka Y., Yanagisawa C., et al. Occurrence of vancomycin-intermediate-resistant Staphylococcus aureus in Japan. J Infect Chemother 13 2 (2007) 118-121
48. Chuang Y.Y., Huang Y.C., Lee C.Y., et al. Methicillin-resistant Staphylococcus aureus bacteraemia in neonatal intensive care units: an analysis of 90 episodes. Acta Paediatr 93 6 (2004) 786-790
49. Frederiksen B., Christiansen P., and Knudsen F.U. Acute osteomyelitis and septic arthritis in the neonate, risk factors and outcome. Eur J Pediatr 152 7 (1993) 577-580
50. Korakaki E., Aligizakis A., Manoura A., et al. Methicillin-resistant Staphylococcus aureus osteomyelitis and septic arthritis in neonates: diagnosis and management. Jpn J Infect Dis 60 2-3 (2007) 129-131
51. Wang C.L., Wang S.M., Yang Y.J., et al. Septic arthritis in children: relationship of causative pathogens, complications, and outcome. J Microbiol Immunol Infect 36 1 (2003) 41-46
52. Saiman L., Prince A., and Gersony W.M. Pediatric infective endocarditis in the modern era. J Pediatr 122 6 (1993) 847-853
53. Valente A.M., Jain R., Scheurer M., et al. Frequency of infective endocarditis among infants and children with Staphylococcus aureus bacteremia. Pediatrics 115 1 (2005) E15-E19
54. Friedland I.R., du Plessis J., and Cilliers A. Cardiac complications in children with Staphylococcus aureus bacteremia. J Pediatr 127 5 (1995) 746-748
55. Kaufman D., and Fairchild K.D. Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clin Microbiol Rev 17 3 (2004) 638-680 table of contents
56. Davenport M., and Doig C.M. Wound infection in pediatric surgery: a study in 1094 neonates. J Pediatr Surg 28 1 (1993) 26-30
57. Rodrigues M.M., Patrocinio S.J., and Rodrigues M.G. Staphylococcus aureus meningitis in children: a review of 30 community-acquired cases. Arq Neuropsiquiatr 58 3B (2000) 843-851
58. Krcmery Jr. V., Filka J., Uher J., et al. Ciprofloxacin in treatment of nosocomial meningitis in neonates and in infants: report of 12 cases and review. Diagn Microbiol Infect Dis 35 1 (1999) 75-80
59. Kluytmans J.A., Mouton J.W., VandenBergh M.F., et al. Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 17 12 (1996) 780-785
60. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group. J Am Soc Nephrol 7 11 (1996) 2403-2408
61. Sandri A.M., Dalarosa M.G., Ruschel de Alcantara L., et al. Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Infect Control Hosp Epidemiol 27 2 (2006) 185-187
62. Stein M., Navon-Venezia S., Chmelnitsky I., et al. An outbreak of new, nonmultidrug-resistant, methicillin-resistant Staphylococcus aureus strain (SCCmec type iiia variant-1) in the neonatal intensive care unit transmitted by a staff member. Pediatr Infect Dis J 25 6 (2006) 557-559
63. Hitomi S., Kubota M., Mori N., et al. Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment. J Hosp Infect 46 2 (2000) 123-129
64. Simor A.E., Stuart T.L., Louie L., et al. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MRSA) in Canadian hospitals. Antimicrob Agents Chemother 51 11 (2007) 3880-3886
65. Jones J.C., Rogers T.J., Brookmeyer P., et al. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin Infect Dis 45 5 (2007) 541-547
66. Machado J.K., Feferbaum R., Kobayashi C.E., et al. Vancomycin pharmacokinetics in preterm infants. Clinics 62 4 (2007) 405-410
67. Gabriel M.H., Kildoo III G.C., Gennrich J.L., et al. Prospective evaluation of a vancomycin dosage guideline for neonates. Clin Pharm 10 2 (1991) 129-132
68. Anderson B.J., Allegaert K., Van den Anker J.N., et al. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance. Br J Clin Pharmacol 63 1 (2007) 75-84
69. Kearns G.L., Jungbluth G.L., Abdel-Rahman S.M., et al. Impact of ontogeny on linezolid disposition in neonates and infants. Clin Pharmacol Ther 74 5 (2003) 413-422
70. Saiman L., Goldfarb J., Kaplan S.A., et al. Safety and tolerability of linezolid in children. Pediatr Infect Dis J 22 9 Suppl (2003) S193-S200
71. Tsuji B.T., and Rybak M.J. E-test synergy testing of clinical isolates of Staphylococcus aureus demonstrating heterogeneous resistance to vancomycin. Diagn Microbiol Infect Dis 54 1 (2006) 73-77
72. Abramson M.A., and Sexton D.J. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs?. Infect Control Hosp Epidemiol 20 6 (1999) 408-411
73. Chaix C., Durand-Zaleski I., Alberti C., et al. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 282 18 (1999) 1745-1751
74. Clancy M., Graepler A., Wilson M., et al. Active screening in high-risk units is an effective and cost-avoidant method to reduce the rate of methicillin-resistant Staphylococcus aureus infection in the hospital. Infect Control Hosp Epidemiol 27 10 (2006) 1009-1017
75. Larson E.L., Cimiotti J., Haas J., et al. Effect of antiseptic handwashing vs alcohol sanitizer on health care-associated infections in neonatal intensive care units. Arch Pediatr Adolesc Med 159 4 (2005) 377-383
76. Gerber S.I., Jones R.C., Scott M.V., et al. Management of outbreaks of methicillin-resistant Staphylococcus aureus infection in the neonatal intensive care unit: a consensus statement. Infect Control Hosp Epidemiol 27 2 (2006) 139-145
77. Roberts R.B., de Lencastre A., Eisner W., et al. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in 12 New York hospitals: MRSA Collaborative Study Group. J Infect Dis 178 1 (1998) 164-171
78. Bootsma M.C., Diekmann O., and Bonten M.J. Controlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing. Proc Natl Acad Sci U S A 103 14 (2006) 5620-5625
79. Stoll B.J., Gordon T., Korones S.B., et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 129 1 (1996) 63-71
80. Fridkin S.K., Kaufman D., Edwards J.R., et al. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004. Pediatrics 117 5 (2006) 1680-1687
81. Kossoff E.H., Buescher E.S., and Karlowicz M.G. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J 17 6 (1998) 504-508
82. Rabalais G.P., Samiec T.D., Bryant K.K., et al. Invasive candidiasis in infants weighing more than 2500 grams at birth admitted to a neonatal intensive care unit. Pediatr Infect Dis J 15 4 (1996) 348-352
83. Feja K.N., Wu F., Roberts K., et al. Risk factors for candidemia in critically ill infants: a matched case-control study. J Pediatr 147 2 (2005) 156-161
84. Jarvis W.R. The epidemiology of colonization. Infect Control Hosp Epidemiol 17 1 (1996) 47-52
85. el-Mohandes A.E., Johnson-Robbins L., Keiser J.F., et al. Incidence of Candida parapsilosis colonization in an intensive care nursery population and its association with invasive fungal disease. Pediatr Infect Dis J 13 6 (1994) 520-524
86. Rowen J.L., Rench M.A., Kozinetz C.A., et al. Endotracheal colonization with Candida enhances risk of systemic candidiasis in very low birth weight neonates. J Pediatr 124 5 Pt 1 (1994) 789-794
87. Baley J.E., Kliegman R.M., Boxerbaum B., et al. Fungal colonization in the very low birth weight infant. Pediatrics 78 2 (1986) 225-232
88. Shattuck K.E., Cochran C.K., Zabransky R.J., et al. Colonization and infection associated with Malassezia and Candida species in a neonatal unit. J Hosp Infect 34 2 (1996) 123-129
89. Waggoner-Fountain L.A., Walker M.W., Hollis R.J., et al. Vertical and horizontal transmission of unique Candida species to premature newborns. Clin Infect Dis 22 5 (1996) 803-808
90. Strausbaugh L.J., Sewell D.L., Ward T.T., et al. High frequency of yeast carriage on hands of hospital personnel. J Clin Microbiol 32 9 (1994) 2299-2300
91. Brown A.J., Odds F.C., and Gow N.A. Infection-related gene expression in Candida albicans. Curr Opin Microbiol 10 4 (2007) 307-313
92. Kumamoto C.A., and Vinces M.D. Contributions of hyphae and hypha-co-regulated genes to Candida albicans virulence. Cell Microbiol 7 11 (2005) 1546-1554
93. Douglas L.J. Candida biofilms and their role in infection. Trends Microbiol 11 1 (2003) 30-36
94. Pearlman S.A., Higgins S., Eppes S., et al. Infective endocarditis in the premature neonate. Clin Pediatr (Phila) 37 12 (1998) 741-746
95. Cohen-Wolkowiez M., Smith P.B., Mangum B., et al. Neonatal Candida meningitis: significance of cerebrospinal fluid parameters and blood cultures. J Perinatol 27 2 (2007) 97-100
96. Smith P.B., Benjamin Jr. D.K., Alexander B.D., et al. Quantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting. Clin Vaccine Immunol 14 7 (2007) 924-925
97. Lopez Sastre J.B., Coto Cotallo G.D., and Fernandez Colomer B. Neonatal invasive candidiasis: a prospective multicenter study of 118 cases. Am J Perinatol 20 3 (2003) 153-163
98. Frattarelli D.A., Reed M.D., Giacoia G.P., et al. Antifungals in systemic neonatal candidiasis. Drugs 64 9 (2004) 949-968
99. Sanchez P.J., Siegel J.D., and Fishbein J. Candida endocarditis: successful medical management in three preterm infants and review of the literature. Pediatr Infect Dis J 10 3 (1991) 239-243
100. Benjamin D.K., DeLong E., Cotten C.M., et al. Mortality following blood culture in premature infants: increased with gram-negative bacteremia and candidemia, but not gram-positive bacteremia. J Perinatol 24 3 (2004) 175-180
101. Smith P.B., Morgan J., Benjamin J.D., et al. Excess costs of hospital care associated with neonatal candidemia. Pediatr Infect Dis J 26 3 (2007) 197-200
102. Manzoni P., Stolfi I., Pugni L., et al. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med 356 24 (2007) 2483-2495
103. Kaufman D., Boyle R., Hazen K.C., et al. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 345 23 (2001) 1660-1666
104. Kaufman D., Boyle R., Hazen K.C., et al. Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight. J Pediatr 147 2 (2005) 172-179
105. Healy C.M., Baker C.J., Zaccaria E., et al. Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. J Pediatr 147 2 (2005) 166-171
106. Clerihew L., Austin N., and McGuire W. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev 4 (2007) CD003850
107. Bertini G., Perugi S., Dani C., et al. Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants. J Pediatr 147 (2005) 162-165
108. Long S.S., and Stevenson D.K. Reducing Candida infections during neonatal intensive care: management choices, infection control, and fluconazole prophylaxis. J Pediatr 147 2 (2005) 135-141